TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AstraZeneca AB
Closing information (x1000 DKK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
110,420,198
|
82,938,788
|
79,511,714 |
| Financial expenses |
1,017,719
|
338,843
|
743,384 |
| Earnings before taxes |
-13,807,035
|
16,739,292
|
26,771,464 |
| EBITDA |
19,746,961
|
18,699,638
|
27,736,455 |
| Total assets |
180,465,074
|
229,820,782
|
235,016,853 |
| Current assets |
22,558,886
|
23,235,484
|
17,738,939 |
| Current liabilities |
16,673,088
|
14,730,955
|
17,581,813 |
| Equity capital |
141,336,810
|
190,175,180
|
193,963,757 |
| - share capital |
1,372,551
|
1,493,528
|
1,522,344 |
| Employees (average) |
6,875
|
6,814
|
6,633 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
78.3%
|
82.7%
|
82.5% |
| Turnover per employee |
16,061
|
12,172
|
11,987 |
| Profit as a percentage of turnover |
-12.5%
|
20.2%
|
33.7% |
| Return on assets (ROA) |
-7.1%
|
7.4%
|
11.7% |
| Current ratio |
135.3%
|
157.7%
|
100.9% |
| Return on equity (ROE) |
-9.8%
|
8.8%
|
13.8% |
| Change turnover |
34,199,509
|
4,932,132
|
14,683,134 |
| Change turnover % |
45%
|
6%
|
23% |
| Chg. No. of employees |
61
|
181
|
483 |
| Chg. No. of employees % |
1%
|
3%
|
8% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.